Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Hourly Titrated Misoprostol Versus Vaginal Dinoprostone and Misoprostol for Cervical Ripening and Labor Induction: Randomized Clinical Trial

NCT02902653 is registered in ClinicalTrials.gov with Oihane Lapuente Ocamica as lead sponsor.

NCT NCT02902653
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02902653 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Hourly Titrated Misoprostol Versus Vaginal Dinoprostone and Misoprostol for Cervical Ripening and Labor Induction: Randomized Clinical Trial
Lead sponsor
Oihane Lapuente Ocamica
Phase
Phase 4
Overall status
Unknown status
Start date
September 30, 2016
Completion date
September 30, 2020
Enrollment
372 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

labor, induced